Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana Inc. (NYSE: HUM) announced that its Kentucky HMO plan has received a 5-star quality rating for the 2022 plan year from the Centers for Medicare and Medicaid Services (CMS). This rating, awarded to only four Medicare Advantage plans nationwide, underscores Humana’s commitment to high-quality care and patient-centered outcomes. Humana’s collaborations with local health providers have enhanced care accessibility for members. The Medicare Advantage enrollment period begins on Oct. 15, allowing eligible individuals to select plans with top ratings.
Humana Inc. (NYSE: HUM) achieved significant success in the 2022 Medicare Star Ratings, receiving a record four 5-star ratings across its contracts, covering around 527,000 members in Florida, Louisiana, Tennessee, and Kentucky. Additionally, it secured 4.5-star ratings for eight Medicare Advantage contracts, impacting over 1.6 million members. Approximately 97% of Humana's Medicare Advantage members are enrolled in plans rated 4 stars and above. The company emphasizes its commitment to high-quality care and customer service as it continues to navigate healthcare delivery challenges amidst the COVID-19 pandemic.
Humana Inc. (NYSE: HUM) is launching a new affordable Medicare Advantage PPO plan in 37 rural counties of Eastern North Carolina, aiming to provide enhanced healthcare options during the upcoming Medicare Advantage Annual Election Period from Oct. 15 to Dec. 7, 2021, with coverage starting Jan. 1, 2022. The plan features a $0 premium, low copays for various services, and special support for COVID patients. Additionally, it includes benefits for veterans and is designed to integrate care effectively.
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), has announced a $200,000 donation to support Hurricane Ida recovery efforts in Louisiana. This donation aims to assist communities affected by the hurricane's devastation, which includes flooding and damage to homes. The funds will be distributed via the Greater New Orleans Foundation, focusing on urgent recovery needs. The Humana Foundation has a history of supporting disaster relief efforts, emphasizing food and financial security.
Humana Foundation has awarded $1.8 million to various nonprofit organizations in Louisville, enhancing its total contributions to over $10 million since 2018. This funding is part of its Community Partners Program, aimed at improving health equity by addressing social determinants of health. The recipients, totaling 30 organizations, will utilize the funds for initiatives in education, community engagement, and health access. The Foundation emphasizes support for marginalized communities during critical times.
Humana and the University of Mississippi Medical Center (UMMC) have entered an in-network agreement, enhancing healthcare access for Humana Medicare Advantage HMO and PPO members in Mississippi. This agreement, effective August 1, 2021, allows members to receive care at UMMC in Jackson and Grenada, as well as at Holmes County Hospital in Lexington. Humana aims to strengthen its commitment to member health through this expanded network, which aligns with UMMC's strategic priority to improve statewide healthcare accessibility.
Humana Inc. (NYSE: HUM) will release its 3Q21 financial results on November 3, 2021 at 6:30 a.m. Eastern time. A conference call will follow at 9:00 a.m. Eastern time to discuss results and earnings guidance. Interested parties can call 888-625-7430. For those unable to attend, a replay will be available shortly after the event. The earnings announcement will include non-GAAP financial measures, with reconciliations provided in the release available on the Investor Relations page.
Humana has signed an in-network agreement with Kelsey-Seybold Clinic to expand access to care for members of its Medicare Advantage HMO plans starting January 1, 2022. This collaboration will provide Houston-area members with access to over 26 Kelsey-Seybold locations and more than 500 providers across 55 medical specialties. The partnership emphasizes Humana's commitment to value-based care, enhancing personalized and coordinated health services for Medicare beneficiaries.
Humana Inc. (NYSE: HUM) announced a $25 million investment to enhance affordable housing in states including Florida, Georgia, and Texas. This initiative aims to address housing stability as a critical social determinant of health, particularly for Medicaid-eligible individuals. The funds will be distributed through three syndicated funds focusing on increasing affordable housing capacity. Humana's strategy includes partnerships to offer eviction prevention and support for vulnerable populations, reflecting its commitment to health equity.
Humana and Curant Health have launched a pilot program targeting Chronic Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD) among Humana members. The initiative focuses on improving medication adherence and aims to reduce health care costs. Through a randomized control trial, the collaboration intends to enhance patient safety and decrease hospital admissions. Humana emphasizes its commitment to medication adherence while Curant Health showcases its high-touch clinical support model, promising to better patient outcomes.